An anonymous director reports
RAVENQUEST PROVIDES BIWEEKLY STATUS
Ravenquest Biomed Inc. has provided its biweekly status update on the delay of filing its annual financial statements and accompanying management's discussion and analysis for the financial year ended Oct. 31, 2019. As previously announced, the company plans to file the annual filings on or before May 1, 2020.
Ravenquest management confirms that it is working diligently to meet the company's obligations relating to its annual filings and that, since it announced a delay of its annual filings, there is no material change to the information set out in the filings notice that has not been generally disclosed, and there has been no failure by the company in fulfilling its stated intentions with respect to satisfying the provisions of the alternative information guidelines set out in National Policy 12-203 (Management Cease Trade Orders). While subject to a management cease trade under NP 12-203, the company will continue to comply with the provisions of the alternative information guidelines under NP 12-203 by issuing biweekly status reports until it has satisfied the necessary filing requirements.
About Ravenquest Biomed Inc.
Ravenquest is a diversified publicly traded cannabis company focused upon cannabis production, management services, and consulting and specialized research and development.
We seek Safe Harbor.
© 2021 Canjex Publishing Ltd. All rights reserved.